SC 13D Filing

Company

Pasithea Therapeutics Corp.

Filed

June 1, 2022

Accession Number

0001493152-22-015556

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →